Rating and target price
The majority of Wall Street analysts providing recommendations on Procter & Gamble (PG) stock maintain a neutral outlook. Wall Street expects near-term cost headwinds and unfavorable currency rates to hurt the company’s net sales and EPS growth rate. However, innovation-driven products, productivity savings, and a lower effective tax rate are projected to support the top and bottom lines.
Among the 24 analysts covering PG stock, 16 analysts suggest a “hold,” seven analysts maintain a “buy,” and one analyst suggests a “sell.” Wall Street has a consensus target price of $89.23 per share on PG stock, which implies a downside of 3.4% based on its closing price of $92.41 as of November 9.
Procter & Gamble stock is trading at 21.0x its estimated fiscal 2019 EPS of $4.41 and at 19.6x the fiscal 2020 estimated EPS of $4.72. Both these ratios look unattractive based on the projected growth rates of 4.5% and 7.0%, respectively, in those periods.
In comparison, Kimberly-Clark stock is trading at a forward PE multiple of 16.5x. Meanwhile, Colgate-Palmolive, Clorox, and Church & Dwight are trading at forward PE ratios of 21.7x, 24.9x, and 27.4x, respectively.